The Second Hospital of Tianjin Medical University, Department of Rheumatology and Immunology, Tianjin, 300211, China.
The Second Hospital of Tianjin Medical University, Department of Nephrology, Tianjin, 300211, China.
ChemMedChem. 2022 Feb 4;17(3):e202100570. doi: 10.1002/cmdc.202100570. Epub 2021 Nov 10.
The treatment of subcutaneous abscess caused by drug-resistant bacteria is facing great difficulties and receiving more attention. In this work, we employed BSA-CuS nanoparticles as a photothermal reagent to apply photothermal therapy (PTT) to combat drug-resistant bacteria in vitro and subcutaneous abscess in vivo. The BSA-CuS nanoparticles were found to be stable and biocompatible without cytotoxicity toward NIH3T3 and 4T1 cells. In vitro experiments showed that three species of drug-resistant pathogens, including Escherichia coli, Staphylococcus aureus, and Candida albicans, could be effectively sterilized under co-incubation with BSA-CuS nanoparticles and then irradiation with 1064 nm NIR laser via tissue penetration. BSA-CuS nanoparticles together with 1064 nm NIR laser irradiation could also effectively diminish subcutaneous abscesses caused by drug-resistant bacteria on mice under PTT and depth PTT without causing any serious side effects and organic damage in vivo.That is OK, thank you!
BSA-CuS 纳米粒子作为光热试剂,通过光热疗法(PTT)在体外对抗耐药菌和体内皮下脓肿。
BSA-CuS 纳米粒子被发现是稳定的且对 NIH3T3 和 4T1 细胞没有细胞毒性,生物相容性好。
体外实验表明,三种耐药病原体,包括大肠杆菌、金黄色葡萄球菌和白色念珠菌,在与 BSA-CuS 纳米粒子共孵育后,再用 1064nm 的近红外激光照射,通过组织穿透,可有效杀菌。
BSA-CuS 纳米粒子与 1064nm 的近红外激光照射相结合,也可以在 PTT 和深度 PTT 下有效减少耐药菌引起的小鼠皮下脓肿,而不会在体内引起任何严重的副作用和有机损伤。